Tolerogenic CD11c + dendritic cells regulate CD4 + Tregs in replacing delayed ischemic preconditioning to alleviate ischemia–reperfusion acute kidney injury
The FASEB Journal · 2024
DOI: 10.1096/fj.202302299rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2024. Verfasst von Pingping Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, General Hospital of Ningxia Medical University, Yinchuan, China. Hauptthemen laut MEDLINE: Acute Kidney Injury, Ischemic Preconditioning, Reperfusion Injury. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Ningxia Province.
Abstract (Originalsprache)
Ischemia–reperfusion injury (IRI) is one of the primary clinical causes of acute kidney injury (AKI). The key to IRI lies in immune‐inflammatory damage, where dendritic cells (DCs) play a central role in eliciting immune responses within the context of inflammation induced by ischemia–reperfusion. Our previous study has confirmed that delayed ischemic preconditioning (DIPC) can reduce the kidney injury by mediating DCs to regulate T‐cells. However, the clinical feasibility of DIPC is limited, as pre‐clamping of the renal artery is not applicable for the prevention and treatment of ischemia–reperfusion acute kidney injury (I/R‐AKI) in clinical patients. Therefore, the infusion of DCs as a substitute for DIPC presents a more viable strategy for preventing renal IRI. In this study, we further evaluated the impact and mechanism of infused tolerogenic CD11c + DCs on the kidneys following IRI by isolating bone marrow‐derived dendritic cells and establishing an I/R‐AKI model after pre‐infusion of DCs. Renal function was significantly improved in the I/R‐AKI mouse model after pre‐infused with CD11c + DCs. The pro‐inflammatory response and oxidative damage were reduced, and the levels of T helper 2 (Th2) cells and related anti‐inflammatory cytokines were increased, which was associated with the reduction of autologous DCs maturation mediated by CD11c + DCs and the increase of regulatory T‐cells (Tregs). Next, knocking out CD11c + DCs, we found that the reduced immune protection of tolerogenic CD11c + DCs reinfusion was related to the absence of own DCs. Together, pre‐infusion of tolerogenic CD11c + DCs can replace the regulatory of DIPC on DCs and T‐cells to alleviate I/R‐AKI. DC vaccine is expected to be a novel avenue to prevent and treat I/R‐AKI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, General Hospital of Ningxia Medical University, Yinchuan, China.
- Department of Clinical Medicine, Ningxia Medical University, Yinchuan, China.
- Ningxia Key Laboratory of Stem Cell and Regenerative Medicine, General Hospital of Ningxia Medical University, Yinchuan, China.
- Department of Basic Medicine, Ningxia Medical University, Yinchuan, China.
ORCID-Profile: Pingping Wang, Chunyao Li, Tao Peng, Longzhu Ruan, Aijie Wu, Jiaojiao Zhu, Wenlu Shi, Menghua Chen, Ting Zhang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Ningxia Province
Zitieren
APA
Wang, P., Li, C., Peng, T., Ruan, L., Wu, A., Zhu, J., Shi, W., Chen, M., & Zhang, T. (2024). Tolerogenic CD11c + dendritic cells regulate CD4 + Tregs in replacing delayed ischemic preconditioning to alleviate ischemia–reperfusion acute kidney injury. The FASEB Journal. https://doi.org/10.1096/fj.202302299rr
Vancouver
Wang P, Li C, Peng T, Ruan L, Wu A, Zhu J, et al. Tolerogenic CD11c + dendritic cells regulate CD4 + Tregs in replacing delayed ischemic preconditioning to alleviate ischemia–reperfusion acute kidney injury. The FASEB Journal. 2024. doi:10.1096/fj.202302299rr
BibTeX
@article{Wang2024,
author = {Wang, Pingping and Li, Chunyao and Peng, Tao and Ruan, Longzhu and Wu, Aijie and Zhu, Jiaojiao and Shi, Wenlu and Chen, Menghua and Zhang, Ting},
title = {Tolerogenic CD11c + dendritic cells regulate CD4 + Tregs in replacing delayed ischemic preconditioning to alleviate ischemia–reperfusion acute kidney injury},
journal = {The FASEB Journal},
year = {2024},
doi = {10.1096/fj.202302299rr}
}
EUVIMED